Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

May 6, 2024

https://www.globenewswire.com/news-release/2024/05/06/2875735/0/en/Real-World-Long-Term-Data-Demonstrate-Sustained-Benefits-of-Aquablation-Therapy-for-Men-with-Benign-Prostatic-Hyperplasia.html

SAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (Nasdaq:PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced long-term, real-world data showcasing the benefits of Aquablation therapy for the treatment of symptomatic benign prostatic hyperplasia (BPH) at both academic and commercial settings. The results were presented this past weekend at the American Urological Association (AUA) Annual Meeting in San Antonio, Texas.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.